Safety and Efficacy of IQP-AK-102 in Reducing Appetite

NCT02041754 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Weight Loss
Appetite Modulation (Focus of Study)

Interventions

DEVICE: IQP-AK-102
DEVICE: Placebo

Sponsor

InQpharm Group